Copaxone nod a booster dose for Natco
Settlement of patents for higher dosage can add wings05-10-2017
05-10-2017
Press Release / Media Release
NATCO's marketing partner Mylan receives final approval of generic Glatiramer Acetate,for both 20 mg/mL and 40 mg/mL versions04-10-2017
Scrutinizer's Report
Scrutinizers Report for the Annual General Meeting held on 28th September, 201703-10-2017
Natco Pharma to expand API facility in TN with Rs 100 cr investment
At a time when the pharmaceutical industry in the State are complaining lack of government support in the State, Hyderabad-based Natco Pharma is planning to expand its Active Pharmaceutical Ingredient (API) and intermediates manufacturing facility and R&D in Tamil Nadu. The company is looking at investing in its existing facility, in Thiruvallur District.The company would be investing around Rs 100 crore in addition to the existing investmenbt of Rs 86.82 crore in the facility to manufacture 16 campaign products at a time, out of 42 API products and R&D activity, with a production capacity of 66.32 tonnes per annum from existing production capacity of 46.267 tonnes per annum. The proposed expansion is in a total land of 10.57 hectre in possession of the company.According to an environmental impact assessment report submitted in connection with the expansion plan, the expansion is in order to meet the growing market demand for pharmceutical products in the country.The proposed .03-10-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Natco Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-09-2017
Outcome of AGM
Proceedings and outcome of the Annual General Meeting held on today 28th September, 201728-09-2017
Natco Pharma: Health begins at home
Strength in the domestic market has held the company in good stead23-09-2017
Natco Pharma's niche portfolio an opportunity
The stock price correction can be considered as a good opportunity for long-term investors05-09-2017
Fixes Book Closure for AGM
Natco Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2017 to September 28, 2017 (both days inclusive) for the purpose of 34th Annual General Meeting (AGM) of the Company to be held on September 28, 2017.30-08-2017
Fixes Book Closure For Annual General Meeting
Register of Members and Transfer books of the company will remain closed from Friday, the 22nd Day of September, 2017 to Thursday, the 28th day of September, 2017 (both days inclusive)29-08-2017